MTP halts human albumin sales in Japan
This article was originally published in Scrip
Executive Summary
Japan's Mitsubishi Tanabe Pharma (MTP) has halted sales of a novel recombinant human serum albumin product in its home market after it emerged that some test data may have been falsified.